See more : S2 Resources Ltd (S2R.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Yestar Healthcare Holdings Company Limited (2393.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yestar Healthcare Holdings Company Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- iROC Co., Ltd. (3555.TWO) Income Statement Analysis – Financial Results
- Tuesday Morning Corporation (TUEM) Income Statement Analysis – Financial Results
- Pendal Group Limited (PDL.AX) Income Statement Analysis – Financial Results
- Standard Surfactants Limited (STDSFAC.BO) Income Statement Analysis – Financial Results
- Broncus Holding Corporation (2216.HK) Income Statement Analysis – Financial Results
Yestar Healthcare Holdings Company Limited (2393.HK)
About Yestar Healthcare Holdings Company Limited
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain activities; and provision of freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.91B | 4.29B | 4.93B | 4.11B | 4.90B | 4.45B | 3.93B | 3.02B | 2.45B | 1.53B | 1.17B | 955.82M |
| Cost of Revenue | 2.40B | 3.59B | 4.08B | 3.30B | 3.64B | 3.25B | 2.82B | 2.26B | 1.94B | 1.27B | 963.90M | 788.51M |
| Gross Profit | 512.78M | 708.71M | 848.70M | 806.88M | 1.27B | 1.20B | 1.11B | 766.33M | 517.41M | 263.47M | 209.44M | 167.31M |
| Gross Profit Ratio | 17.60% | 16.50% | 17.21% | 19.65% | 25.81% | 26.96% | 28.16% | 25.36% | 21.08% | 17.20% | 17.85% | 17.50% |
| Research & Development | 0.00 | 21.15M | 1.24M | 648.00K | 463.00K | 357.00K | 593.00K | 1.06M | 3.43M | 1.99M | 1.57M | 0.00 |
| General & Administrative | 264.22M | 336.10M | 320.67M | 336.76M | 357.15M | 316.86M | 285.81M | 226.65M | 141.88M | 58.67M | 62.95M | 41.10M |
| Selling & Marketing | 116.36M | 308.12M | 336.34M | 286.70M | 296.96M | 231.66M | 174.56M | 116.81M | 83.36M | 57.01M | 52.43M | 49.64M |
| SG&A | 380.58M | 786.22M | 664.33M | 648.74M | 654.11M | 548.52M | 460.37M | 343.46M | 225.24M | 115.68M | 115.38M | 90.74M |
| Other Expenses | 132.20M | -786.36M | -16.96M | -801.91M | -47.47M | -22.79M | -17.02M | -6.95M | -6.97M | -5.54M | -1.48M | -7.00K |
| Operating Expenses | 512.78M | 1.52B | 669.21M | 1.39B | 687.10M | 567.69M | 457.39M | 329.86M | 221.60M | 115.03M | 111.69M | 86.43M |
| Cost & Expenses | 2.91B | 5.11B | 4.75B | 4.69B | 4.33B | 3.82B | 3.28B | 2.59B | 2.16B | 1.38B | 1.08B | 874.94M |
| Interest Income | 2.39M | 293.00M | 119.54M | 112.73M | 127.32M | 121.45M | 118.51M | 52.67M | 15.88M | 1.39M | 4.08M | 3.57M |
| Interest Expense | 164.71M | 298.58M | 127.79M | 124.08M | 133.16M | 123.63M | 123.40M | 55.85M | 19.08M | 5.73M | 5.35M | 2.65M |
| Depreciation & Amortization | 171.06M | 230.78M | 232.91M | 251.25M | 249.71M | 152.95M | 139.06M | 92.84M | 57.42M | 16.82M | 12.59M | 10.10M |
| EBITDA | 376.81M | 19.13M | 315.89M | -317.26M | 766.38M | 802.43M | 783.62M | 514.76M | 349.60M | 164.61M | 106.64M | 94.32M |
| EBITDA Ratio | 12.94% | 1.03% | 6.41% | 7.44% | 15.63% | 18.04% | 19.96% | 17.03% | 14.24% | 10.75% | 9.09% | 9.87% |
| Operating Income | 171.04M | -77.51M | 184.37M | 158.14M | 611.20M | 650.31M | 645.45M | 422.88M | 292.17M | 147.79M | 94.06M | 82.86M |
| Operating Income Ratio | 5.87% | -1.81% | 3.74% | 3.85% | 12.47% | 14.62% | 16.44% | 13.99% | 11.90% | 9.65% | 8.02% | 8.67% |
| Total Other Income/Expenses | -130.00M | -407.26M | -123.18M | -905.36M | -192.63M | -169.06M | -138.43M | -38.01M | -12.25M | -739.00K | 1.18M | -1.29M |
| Income Before Tax | 41.04M | -1.11B | 59.94M | -692.60M | 450.89M | 509.69M | 529.92M | 383.81M | 279.93M | 147.05M | 93.67M | 81.57M |
| Income Before Tax Ratio | 1.41% | -25.79% | 1.22% | -16.86% | 9.20% | 11.46% | 13.49% | 12.70% | 11.40% | 9.60% | 7.98% | 8.53% |
| Income Tax Expense | 39.56M | 86.75M | 47.26M | 47.30M | 149.64M | 160.15M | 179.34M | 113.88M | 81.41M | 43.50M | 28.33M | 23.54M |
| Net Income | -13.89M | -992.23M | 3.33M | -590.49M | 202.67M | 251.75M | 249.97M | 201.03M | 162.76M | 100.90M | 65.07M | 56.52M |
| Net Income Ratio | -0.48% | -23.11% | 0.07% | -14.38% | 4.13% | 5.66% | 6.37% | 6.65% | 6.63% | 6.59% | 5.55% | 5.91% |
| EPS | 0.00 | -0.43 | 0.00 | -0.25 | 0.08 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 | 0.04 | 0.03 |
| EPS Diluted | -0.01 | -0.43 | 0.00 | -0.25 | 0.08 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 | 0.04 | 0.03 |
| Weighted Avg Shares Out | 3.48B | 2.33B | 2.35B | 2.36B | 2.39B | 2.18B | 2.18B | 2.18B | 2.01B | 1.87B | 1.46B | 1.87B |
| Weighted Avg Shares Out (Dil) | 2.33B | 2.33B | 2.35B | 2.36B | 2.39B | 2.18B | 2.18B | 2.18B | 2.01B | 1.87B | 1.46B | 1.87B |
Source: https://incomestatements.info
Category: Stock Reports